BioSpace News Archive

Drug Development

Novartis Corporation Release: Phase II Data Showing Clinical Benefits Of Novel Once-Daily Oral Multiple Sclerosis Therapy FTY720 (Fingolimod) Published In New England Journal Of Medicine

September 14, 2006
·
1 min read
Pharm Country

Johnson & Johnson To Participate In Merrill Lynch Conference

September 14, 2006
·
1 min read
Business

Amphion Innovations plc Partner Company WellGen, Inc. Appoints Dr. Kathleen Mullinix As New CEO

September 14, 2006
·
4 min read
BioForest

Xenon Pharmaceuticals Inc. Announces A USD $5M Investment By Takeda Research Investment

September 14, 2006
·
1 min read
Biotech Bay

Lipomics Receives Department Of Defense Grant For Study Using Lipid Analysis To Assess Fitness

September 14, 2006
·
1 min read
Drug Development

AmpliMed Corporation Announces Interim Phase I/II Trial Results For Amplimexon Plus Dacarbazine For Treatment Of Malignant Melanoma

September 14, 2006
·
1 min read
Genetown

Curis, Inc. Named One Of New England’s Fastest Growing Life Sciences Companies In Deloitte’s Technology Fast 50 Program

September 14, 2006
·
1 min read
Business

Primedex Health Systems Reports Third Quarter 2006 Results And Four Imaging Center Acquisitions

September 14, 2006
·
1 min read
Drug Development

Leading Melanoma Specialist Validates Ablative Ability And Systemic Effects Of Provectus Pharmaceuticals Inc. Anti-Cancer Agent PV-10

September 14, 2006
·
1 min read
Bio NC

Best Lab Deals Inc. Announces Limited-Time Promotion On Mechanical mLINE Pipettors

September 14, 2006
·
1 min read